Sign in

    Michael Chang

    Research Analyst at CGS-CIMB

    Michael Chang is the Head of Asian Financials Research at CGS-CIMB Securities, specializing in coverage of the Asian and Hong Kong financial sectors with a focus on companies like AIA Group. Since joining CGS-CIMB as Head in February 2022, he has maintained a 50% success rate on TipRanks, with 3 out of 6 ratings generating profit, although his average return per rating over the last year stands at -7.3%. Chang's career spans major research and analyst roles at institutions including HSBC, Deutsche Bank, ABN AMRO Bank N.V., and Westpac Group, following his dual degrees in Commerce and Law from the University of Sydney. He is recognized for his analytical expertise across Asian financials, though specific professional credential details such as securities licenses are not publicly listed.

    Michael Chang's questions to PRUDENTIAL (PUK) leadership

    Michael Chang's questions to PRUDENTIAL (PUK) leadership • H1 2025

    Question

    Michael Chang from CGS-CIMB Securities asked about the outlook for the agency business in Mainland China and Hong Kong, questioning the drivers behind recruitment and growth sustainability. He also inquired about the capital management framework, specifically how the 2026-2027 buyback amounts were determined and how proceeds from the potential Indian AMC IPO would be returned to shareholders.

    Answer

    CEO Anil Wadhwani explained that a change management program in China is showing early positive signs with a 45% increase in new recruits. He also highlighted Hong Kong's strong, balanced performance. CFO Ben Bulmer stated the capital management update reflects confidence in the business model and a pivot to a total return proposition. He clarified that the timing for returning Indian AMC IPO proceeds is currently indicative due to regulatory restrictions.

    Ask Fintool Equity Research AI

    Michael Chang's questions to PRUDENTIAL (PUK) leadership • Q1 2023

    Question

    Inquired about the specifics of the Hong Kong business recovery, including differences in geographic and product mix compared to pre-COVID levels, reasons for outperformance in the domestic segment, and initiatives driving the positive Q3 outlook in other key markets.

    Answer

    Executives detailed that Hong Kong's Q2 volumes exceeded 2019 levels, with a normalization seen in May/June after an initial spike. The MCV business is geographically diversified, with over 70% from outside the Greater Bay Area. Margins improved in Q2, and the health policy count is trending up. The strong Q3 momentum is also driven by a comeback in Singapore and continued strength in Indonesia and Malaysia, while China's product mix is being deliberately rebalanced for long-term value.

    Ask Fintool Equity Research AI